RxDoctor Payments Data

Christina Rubano, PA

Medical · Waterbury, CTNPI 1316340797

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (58.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Angiodynamics, Inc. at 58.7% of the total. 2025 is the largest year on record at $5,029, 3.2 times the $1,592 reported in 2021. Among medical clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,235in general payments, 2019–2025

Across 207 payments — averaging $39.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$5K
  • Amgen$723
  • Johnson & Johnson$704
  • AbbVie$469
  • GSK$256
  • Optinose US, Inc.$215
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,33040%
  • Education$721%
  • Other$4,83359%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,235 in reported general payments places this provider in the 90th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$47,091
Medicare patients
218
Services billed
747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide144$3,812
Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid11$1,408
Fluocinolone Acetonide18$785
Fluticasone Propionate40$428
Flurbiprofen14$251
Pantoprazole Sodium22$161
Prednisone49$138
Desloratadine13$55
Levocetirizine Dihydrochloride11$38
Meclizine Hcl11$34

Paid to pharmacies, not to this prescriber.

Other medical in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →